Neoleukin Therapeutics Inc (NLTX): NLTX Neoleukin Therapeutics Inc 0.771...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3157
Posts	961308
Boards Moderated	204
Alias Born	09/04/2000

mick

Re: None

Sunday, 06/25/2023 11:34:36 AM

Sunday, June 25, 2023 11:34:36 AM

NLTX
Neoleukin Therapeutics Inc
0.771
0.0109 (1.43%)
Volume: 103,148
Day Range: 0.750101 - 0.8106
Last Trade Time: 5:42:29 PM EDT

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent NLTX News

Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 10:20:01 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 06:34:31 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 06:33:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/26/2024 06:33:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 08:44:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 07:43:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 08:10:58 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2024 08:04:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:54:55 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:53:21 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:51:43 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:29:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:20:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:07:08 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:16:50 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 11:05:00 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:26:22 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:16:35 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:08:52 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:19:20 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 09:18:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 12:01:01 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:58:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:56:12 PM

More NLTX News

InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover